General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

MinorAilments LOGOJuly 6 2015

Patient registration for the Minor Ailments Service in Scotland increased 2.0% to 913,483 people or nearly 18% of the population in 2014-15.

Over 2.1 million items were dispensed under the MAS, accounting for 2.2% of all items dispensed in Scotland’s community pharmacies at a total item cost of £5 million. The average item cost ranged from £2.08 in NHS Greater Glasgow & Clyde to £2.71 in NHS Shetland.

The figures come from the annual prescribing and medicines data published by the Information Services Division of NHS Scotland. It says that all 1,253 active community pharmacies in Scotland had patients registered for MAS by March 31.

“Paracetamol (in all formulations) was the drug most frequently dispensed through the MAS in 2014/15, accounting for 21.4% of items dispensed. This accounts for 5.4% of the total cost of paracetamol items dispensed by community pharmacies in Scotland for that year,” says the report.

The top ten MAS items dispensed in 2014-15 were as follows:

Medicine category Number of Items
paracetamol 462,000
ibuprofen 148,693
Simple Linctus BP 109,398
dimeticone 92,575
emollients 80,437
chlorphenamine maleate 77,399
chloramphenicol 66,599
compound alginic acid preparations 62,733
cetirizine 57,819
clotrimazole 55,621

Links:

ISD Prescribing Statistics - Minor Ailments Service

ISD ‘Prescribing & Medicines: Minor Ailments Service (MAS) Financial Year 2014/15’                

ISD MAS publication summary  

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...